A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 48
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : EC
Long Form : enteric-coated
No. Year Title Co-occurring Abbreviation
2019 Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications. ---
2018 Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High-Risk Patients for Cardiovascular Disease. CV, TX
2017 Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tablets. IR
2017 Enteric Coating and AspirinNonresponsiveness in PatientsWith Type2Diabetes Mellitus. TXB2
2014 Bioavailability of enteric-coated microencapsulated calcium during pregnancy: a randomized crossover trial in Bangladesh. FCA
2014 Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies. AEs, DUs, GI, GUs, LDA, NAP/ESO, NSAIDs
2014 In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia. ET, OD, TX
2013 Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis. PERT
2013 Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery. SLN
10  2013 Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325mg + immediate-release omeprazole 40mg) or enteric-coated aspirin 325mg + enteric-coated omeprazole 40mg - a randomised, phase 1, crossover study. EC-ASA, IR
11  2013 Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel. ---
12  2012 Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium. ---
13  2012 Single-dose pharmacokinetics of different oral sodium nitrite formulations in diabetes patients. IR
14  2011 Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease. BMI, NAFLD
15  2011 Pharmacodynamic evaluation of clopidogrel plus PA32540: the Spaced PA32540 With Clopidogrel Interaction Gauging (SPACING) study. ---
16  2010 Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteers. IR
17  2010 Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone. NSAID, UGI
18  2010 Long-term treatment of cystinosis in children with twice-daily cysteamine. ---
19  2010 Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease. CHD, CV, MACE
20  2009 Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome. PCI, PPIs
21  2008 Effect of food on the antiviral activity of didanosine enteric-coated capsules: a pilot comparative study. CI, ddI
22  2007 Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. AUC, AUC12, IMPDH, MPA, MPAG, MRP-2, UGTs
23  2006 An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study. ---
24  2006 Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers. ---
25  2005 Enteric-coated mycophenolate sodium for transplant immunosuppression. GI, MPA, MPAG
26  2005 Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil. MPA
27  2005 Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. AA, COX, MI, TX
28  2002 Single-dose pharmacokinetics of enteric-coated didanosine in HIV-infected children. ---
29  2001 Tolerability of enteric-coated didanosine capsules compared with didanosine tablets in adults with HIV infection. ddI, GI
30  2001 [Didanosine as a capsule. A reliable drug in a new dosage form]. ---
31  1999 Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis. ---
32  1999 Sustained release and enteric coated NSAIDs: are they really GI safe? GI, NSAIDs, SR
33  1998 Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects. ASA, PRP, TXA2
34  1998 Study of efficacy and tolerance of ketoprofen and diclofenac sodium in the treatment of acute rheumatic and traumatic conditions. VAS
35  1996 Absolute bioavailability of fluoride from disodium monofluorophosphate and enteric-coated sodium fluoride tablets. ---
36  1995 Fluoride therapy of type I osteoporosis. MFP
37  1994 Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. A report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations. ADRs, NSAIDs, SR, SSPV
38  1994 Steady-state pharmacokinetics of enteric-coated naproxen tablets compared with standard naproxen tablets. AUC, Tmax
39  1992 Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis. ---
40  1991 Effectiveness and safety of small vs. large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis: a prospective randomized study. CF, SU, UUA
41  1991 Influence of acid secretory status on absorption of omeprazole from enteric coated granules. ---
42  1990 Application of radiotelemetric technique in evaluating diclofenac sodium absorption after oral administration of various dosage forms in healthy volunteers. HC, SR
43  1990 Bioavailability of enteric-coated sodium fluoride tablets as affected by the administration of calcium supplements at different time intervals. ---
44  1990 Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects. ---
45  1989 Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets. ---
46  1988 In vitro release characteristics of hard shell capsule products coated with aqueous- and organic-based enteric polymers. CAP, DEP, PVAP, SEM, TMA
47  1982 Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function. SA
48  1980 Meal-dependent absorption of enteric-coated sodium valproate. Lp, VPA